| Autor: |
Naini, Arun, Bartetzko, Max Peter, Sanapala, Someswara Rao, Broecker, Felix, Wirtz, Victoria, Lisboa, Marilda P., Parameswarappa, Sharavathi G., Knopp, Daniel, Przygodda, Jessica, Hakelberg, Matthias, Pan, Rosalind, Patel, Axay, Chorro, Laurent, Illenberger, Arthur, Ponce, Christopher, Kodali, Srinivas, Lypowy, Jacqueline, Anderson, Annaliesa S., Donald, Robert G. K., von Bonin, Arne, Pereira, Claney L. |
| Zdroj: |
JACS Au; 20220101, Issue: Preprints |
| Abstrakt: |
Extraintestinal pathogenic Escherichia coli(ExPEC) is a major health concern due to emerging antibiotic resistance. Along with O1A, O2, and O6A, E. coliO25B is a major serotype within the ExPEC group, which expresses a unique O-antigen. Clinical studies with a glycoconjugate vaccine of the above-mentioned O-types revealed O25B as the least immunogenic component, inducing relatively weak IgG titers. To evaluate the immunological properties of semisynthetic glycoconjugate vaccine candidates against E. coliO25B, we here report the chemical synthesis of an initial set of five O25B glycan antigens differing in length, from one to three repeat units, and frameshifts of the repeat unit. The oligosaccharide antigens were conjugated to the carrier protein CRM197. The resulting semisynthetic glycoconjugates induced functional IgG antibodies in mice with opsonophagocytic activity against E. coliO25B. Three of the oligosaccharide–CRM197conjugates elicited functional IgGs in the same order of magnitude as a conventional CRM197glycoconjugate prepared with native O25B O-antigen and therefore represent promising vaccine candidates for further investigation. Binding studies with two monoclonal antibodies (mAbs) revealed nanomolar anti-O25B IgG responses with nanomolar KDvalues and with varying binding epitopes. The immunogenicity and mAb binding data now allow for the rational design of additional synthetic antigens for future preclinical studies, with expected further improvements in the functional antibody responses. Moreover, acetylation of a rhamnose residue was shown to be likely dispensable for immunogenicity, as a deacylated antigen was able to elicit strong functional IgG responses. Our findings strongly support the feasibility of a semisynthetic glycoconjugate vaccine against E. coliO25B. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
